Biovitrum AB cuts staff as it restructures R&D ops

Sweden's Biovitrum AB has restructured its R&D operations, winnowing out about 100 people either through layoffs or by reassigning them to other work. Biovitrum says it will focus on specialist care pharmaceuticals and "is in the process of out-licensing a majority of the company's primary care projects."

- read the Biovitrum release for more info